Literature DB >> 22931976

Outcome of in vitro fertilization in endometriosis-associated infertility: a 5-year database cohort study.

Xiao-Na Lin1, Min-Ling Wei, Xiao-Mei Tong, Wei-Hai Xu, Feng Zhou, Qiong-Xiao Huang, Guo-Feng Wen, Song-Ying Zhang.   

Abstract

BACKGROUND: Endometriosis affects natural fertility through various approaches, and in vitro fertilization (IVF) is a good treatment. But the IVF result of endometriosis patients is still under debate. We investigated the effect of endometriosis on IVF by analyzing the data from a single reproductive center.
METHODS: A retrospective, database-searched cohort study was performed. Relevant information was collected from the electronic records of women who underwent IVF/intracytoplasmic sperm injection between January 2006 and December 2010 in the Assisted Reproductive Unit of Sir Run Run Shaw Hospital. Patients with endometriosis were enrolled the study group. The rest of the women formed the control group. The main outcome was the clinical pregnancy rate. Secondary outcomes were oocytes retrieved number, fertilization rate, high-quality embryo rate, number of high-quality embryo for embryo transplantation, and implantation embryo/high-quality embryo ratio (IE/HQE ratio). Comparisons were performed by the c(2)-test and independent t-test.
RESULTS: The endometriosis group (n = 177) had a markedly lower oocytes retrieved number, fertilization rate, implantation rate, and clinical pregnancy rate (7.6 ± 5.1, 63.6%, 27.7%, and 45.2%, respectively) compared with the non-endometriosis group (n = 4267; 11.8 ± 7.3, 68.4%, 36.2%, and 55.2%, respectively). Stratified analysis showed that this difference was found in the subgroup younger than 35-years old, while only fertilization rate and implantation rate were different in the elder subgroup. The ratio of high-quality embryos transferred is lower in endometriosis group (53.7% vs. 71.8%, P < 0.05), but there is no difference in IE/HQE ratio between two groups. There is no significant difference in fertilization rate, implantation rate, and clinical pregnancy rate between mild and severe endometriosis patients.
CONCLUSIONS: Endometriosis patients suffer a decreasing IVF pregnancy rates mainly caused by reducing oocytes number and fertilization rate, regardless of the severity of the disease. Appropriate intracytoplasmic sperm injection manipulation might improve the outcomes of IVF.

Entities:  

Mesh:

Year:  2012        PMID: 22931976

Source DB:  PubMed          Journal:  Chin Med J (Engl)        ISSN: 0366-6999            Impact factor:   2.628


  12 in total

1.  Endometriosis does not affect live birth rates of patients submitted to assisted reproduction techniques: analysis of the Latin American Network Registry database from 1995 to 2011.

Authors:  Mário Murta; Roberto Carlos Machado; Fernando Zegers-Hochschild; Miguel Angel Checa; Marcos Sampaio; Selmo Geber
Journal:  J Assist Reprod Genet       Date:  2018-06-27       Impact factor: 3.412

2.  The gene expression profile of cumulus cells reveals altered pathways in patients with endometriosis.

Authors:  Adolfo Allegra; Stefania Raimondo; Aldo Volpes; Daniele Fanale; Angelo Marino; Giuseppe Cicero; Giacomo De Leo; Francesca Sammartano; Giulia Allegra; Riccardo Alessandro
Journal:  J Assist Reprod Genet       Date:  2014-08-12       Impact factor: 3.412

3.  Factors affecting clinical outcomes after IVF-ET for infertile young patients with ovarian endometrioma: A 5-year retrospective cohort study.

Authors:  Feng Zhou; Fanxuan Zhao; Xiaoying Jin; Chao Li; Songying Zhang
Journal:  Medicine (Baltimore)       Date:  2022-07-01       Impact factor: 1.817

4.  The impact of endometriosis on IVF/ICSI outcomes.

Authors:  Xiyuan Dong; Xiuhua Liao; Rui Wang; Hanwang Zhang
Journal:  Int J Clin Exp Pathol       Date:  2013-08-15

5.  A case of empty follicle syndrome who conceived after aspiration of an endometrial cyst.

Authors:  Rieko Tanaka; Mariko Murase; Yoshino Aizawa; Miwa Segino; Yumi Ishidera; Masakazu Kitagawa; Kayo Katayama; Kunitomo Takashima; Yasushi Yumura; Hiroshi Yoshida; Hideya Sakakibara; Fumiki Hirahara
Journal:  Reprod Med Biol       Date:  2013-04-13

6.  The role of fertility preservation in patients with endometriosis.

Authors:  L Carrillo; D S Seidman; E Cittadini; D Meirow
Journal:  J Assist Reprod Genet       Date:  2016-01-14       Impact factor: 3.412

7.  Efficacy and safety investigation of Kuntai capsule for the add-back therapy of gonadotropin releasing hormone agonist administration to endometriosis patients: a randomized, double-blind, blank- and tibolone-controlled study.

Authors:  Ji-Ming Chen; Hong-Yan Gao; Yi Ding; Xia Yuan; Qing Wang; Qin Li; Guo-Hua Jiang
Journal:  Chin Med J (Engl)       Date:  2015-02-20       Impact factor: 2.628

8.  The impact of endometriosis on the outcome of Assisted Reproductive Technology.

Authors:  Mireia González-Comadran; Juan Enrique Schwarze; Fernando Zegers-Hochschild; Maria do Carmo B Souza; Ramon Carreras; Miguel Ángel Checa
Journal:  Reprod Biol Endocrinol       Date:  2017-01-24       Impact factor: 5.211

9.  Use of medroxyprogesterone acetate in women with ovarian endometriosis undergoing controlled ovarian hyperstimulation for in vitro fertilization.

Authors:  Haiyan Guo; Yun Wang; Qiuju Chen; Weiran Chai; Lihua Sun; Ai Ai; Yonglun Fu; Qifeng Lyu; Yanping Kuang
Journal:  Sci Rep       Date:  2017-09-20       Impact factor: 4.379

10.  The Impact of Endometriosis on Embryo Quality in in-vitro Fertilization/Intracytoplasmic Sperm Injection: A Systematic Review and Meta-Analysis.

Authors:  Houjin Dongye; Xiaofeng Ji; Xiaopei Ma; Jialun Song; Lei Yan
Journal:  Front Med (Lausanne)       Date:  2021-06-02
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.